CYANOGUANIDINES AND THEIR USE AS ANTIVIRAL AGENTS
This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compou...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
03.01.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
La présente invention concerne : (a) des composés et des sels de ceux-ci qui, entre autres, empêchent la réplication et/ou l'infection par le VRS ; (b) des intermédiaires utiles pour la préparation de tels composés et sels ; (c) des compositions comprenant de tels composés et sels ; (d) des méthodes de préparation de tels intermédiaires, composés, sels et compositions ; (e) des méthodes d'utilisation de tels composés, sels et compositions ; et (f) des nécessaires comprenant de tels composés, sels et compositions. |
---|---|
Bibliography: | Application Number: CA20132877326 |